• Home>
  • Stocks>
  • Glenmark Pharmaceuticals Ltd Share Price
Glenmark Pharmaceuticals Ltd share price logo

Glenmark Pharmaceuticals Ltd Share Price

NSE: GLENMARK

BSE: 532296

Mid Cap

Healthcare Sector

₹1946.20

+2.20

(+0.11%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Glenmark Pharmaceuticals Ltd Stock Performance

as on November 28, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,937.8
    ₹1,958
    downward going graph

    0.43%

    Downside

    0.61%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,275.5
    ₹2,284.8
    downward going graph

    34.46%

    Downside

    17.40%

    Upside

    downward going graph

Glenmark Pharmaceuticals Ltd share price movements today

Previous Close
₹1,944.00
Open
₹1,949.50
Volume
6.88L
Upper Circuit
₹2,138.40
Lower Circuit
₹1,749.60
Day's Low - High
₹1,937.8 - ₹1,958
52 Week Low - High
₹1,275.5 - ₹2,284.8

Glenmark Pharmaceuticals Ltd Historical Returns

1 Month Return
+ 7.1 %
3 Month Return
+ 0.37 %
1 Year Return
+ 30.02 %
3 Year Return
+ 349.69 %
5 Year Return
+ 307.46 %

Glenmark Pharmaceuticals Ltd Fundamentals

as on November 28, 2025 at 4:01 pm IST

Market Cap

₹54,859.84 Cr

Return on Equity (ROE)

6.78

PE Ratio (TTM)

54.33

Return on capital employed (ROCE)

8.94

Industry PE ratio

42.19

Beta (LTM)

0.6

P/B Ratio

1.77

Dividend Yield

0.16

PEG Ratio

0.81

Quarterly Earnings Growth YOY

72.2

EPS (TTM)

37.11

Sector

Pharmaceuticals

Book Value

313.6

Technical Analysis

Bullish

View Technical Analysis

Glenmark Pharmaceuticals Ltd Stock Valuation

as on November 28, 2025 at 4:01 pm IST

Glenmark Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-275.05x)

December 28, 2023

Industry (42.19x)

November 27, 2025

Today (54.33x)

November 27, 2025

Highest (95.94x)

September 14, 2023

LowHigh

Today’s Price to Earnings Ratio: 54.33x

Glenmark Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Glenmark Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Glenmark Pharmaceuticals Ltd image
Glenmark Pharmaceuticals Ltd
BUY54,859.8461.49%0.621,04713,321
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY21,986.139.87%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY17,535.7414.89%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA4,402.14-5.35%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY13,778.5340.27%0.672441,515
See all

Analyst Recommendation on Glenmark Pharmaceuticals Ltd Stock

Based on 12 analysts

BUY

83.33%

Buy

8.33%

Hold

8.33%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Glenmark Pharmaceuticals Ltd. Average target price of ₹2112

Source: S&P Global Market Intelligence

Glenmark Pharmaceuticals Ltd Share Price Target

Get share price movements and forecasts by analysts on Glenmark Pharmaceuticals Ltd.

What analysts predicted

8.64%UPSIDE

Target Price

₹2112

Current Price

₹1946.2

Analyzed by

12 Analysts

High

₹2735

Target

₹2112.00

Low

₹1500

Glenmark Pharmaceuticals Ltd target price ₹2112, a slight upside of 8.64% compared to current price of ₹1946.2. According to 12 analysts rating.

Source: S&P Global Market Intelligence

Glenmark Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest

Investment in Glenmark Pharmaceuticals Ltd Shares on INDmoney has grown by 238.84% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:238.84% versus previous 30 day period

Search interest for Glenmark Pharmaceuticals Ltd Stock has increased by 255% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:255% versus previous 30 day period

Glenmark Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
3,062.75
2,958.37
2,998.47
3,160.69
2,460.29
3,016.01
3,223.3
3,400.5
3,301.9
3,220.13
3,059.33
6,003.79
Other Income
209.43
103.93
19.72
120.43
164.18
797.54
31.49
39.42
31.13
11.69
26.44
200.63
Total Income
3,309.61
3,104.45
3,055.79
3,327.81
2,670.88
3,860.49
3,275.68
3,473.21
3,418.68
3,267.89
3,290.88
6,247.5
Expenses
2,626.15
3,402.33
2,650.74
3,070.52
2,792.07
3,005.39
2,655.97
2,831.88
2,787.32
3,068
3,007.15
5,072.44
Operating Profit
436.6
-443.96
347.73
90.17
-331.78
10.62
567.33
568.62
514.58
152.13
52.18
931.35
Operating Profit Margin %
14.26%
-15.01%
11.6%
2.85%
-13.49%
0.35%
17.6%
16.72%
15.58%
4.72%
1.71%
15.51%
Profit Before Interest, Tax and Depreciation
683.47
-297.89
405.05
257.3
-121.2
855.1
619.71
641.33
631.36
199.89
283.73
1,175.06
Interest
97.11
109.14
111.61
121.46
134.34
148.56
39.58
48.48
52.29
66.71
58.23
66.46
Depreciation
151.51
135.02
142.04
141.45
147.08
151.34
117.79
120.28
122.74
125.21
129.93
141.2
Profit Before Tax
434.85
-542.05
151.4
-5.61
-402.62
555.2
462.34
472.57
456.33
7.97
95.57
967.4
Tax Paid
144.08
-138.91
-21.73
55.95
-71.8
1,769.47
122.09
118.09
108.29
3.59
48.6
356.97
Profit After Tax
290.76
-403.14
173.13
-61.56
-330.82
-1,214.27
340.24
354.49
348.03
4.38
46.97
610.43
Total Net profit including share of profit / Loss from associate company
290.76
-403.14
173.13
-61.56
-330.82
-1,214.27
340.24
354.49
348.03
4.38
46.97
610.43
EPS
9.66
-15.18
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.63
Actual EPS
9.66
-15.18
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.63
Adjusted EPS
9.66
-15.18
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.63
Diluted EPS
9.66
-15.18
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.62

Glenmark Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
8,970.09
8,972.23
9,705.08
10,397.23
10,806.03
12,174.2
11,431.94
11,635.46
13,145.84
Other Income
37.37
91.4
375.32
192.48
94.76
166.67
755.86
1,237.32
113.72
Total Income
9,223.05
9,194.47
10,240.79
10,833.45
11,038.69
12,471.58
12,339.1
13,050.42
13,435.46
Expenses
7,229.93
7,487.7
8,279.67
8,942.89
8,859.55
10,245.52
10,714.08
11,518.72
11,343.18
Operating Profit
1,740.16
1,484.53
1,425.41
1,454.34
1,946.48
1,928.68
717.86
116.74
1,802.66
Operating Profit Margin %
19.4%
16.55%
14.69%
13.99%
18.01%
15.84%
6.28%
1%
13.71%
Profit Before Interest, Tax and Depreciation
1,993.12
1,706.77
1,961.12
1,890.56
2,179.14
2,226.06
1,625.01
1,531.7
2,092.28
Interest
237.32
285.57
334.59
377.32
353.11
298.1
349.04
515.97
207.07
Depreciation
264.37
301.88
325.91
417.17
443.55
486.72
569.17
581.91
486.01
Profit Before Tax
1,491.43
1,119.32
1,300.62
1,096.07
1,382.48
1,441.24
706.8
433.82
1,399.2
Tax Paid
382.67
315.46
375.63
320.11
412.39
447.6
329.4
1,867.34
352.07
Profit After Tax
1,108.75
803.87
924.99
775.97
970.09
993.65
377.4
-1,433.52
1,047.14
Total Net profit including share of profit / Loss from associate company
1,108.75
803.87
924.99
775.97
970.09
993.65
377.4
-1,433.52
1,047.14
EPS
39.29
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
Actual EPS
39.29
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
Adjusted EPS
39.29
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
Diluted EPS
39.28
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.1

Glenmark Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
344.85
657.43
1,648.05
1,324.17
1,392.41
1,131.21
1,108.65
625.39
-265.44
-827.6
Cash Flow from Investing Activities
-950.06
-1,001.34
-1,002.56
-882.52
-773.75
-661.62
-315.74
-515.43
4,386.81
58
Cash Flow from Financing Activities
698.6
543.14
-468.49
-738.74
-444.65
-441.78
-463.11
75.27
-3,906.13
787.04
Net Cash Flow
93.39
199.24
176.99
-297.08
174
27.82
272.43
32.5
215.24
17.44

Glenmark Pharmaceuticals Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
46.65%
46.65%
46.65%
46.65%
46.65%
46.64%
46.65%
46.65%
46.65%
46.65%
46.65%
46.65%
DII
10.69%
10.41%
9.11%
10.32%
10.92%
13.36%
13.92%
13.21%
13.85%
14.6%
17.64%
18.61%
FII
0%
0%
0%
24.8%
23.71%
21.38%
20.98%
23.05%
23.51%
23.16%
20.62%
20.73%
Government
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
Public
19.43%
20.45%
18.68%
18.2%
18.69%
18.58%
18.41%
17.06%
15.96%
15.56%
15.06%
13.97%
Total Outstanding Shares
28,21,68,156
28,21,68,156
28,21,68,156
28,21,68,156
28,21,68,156
28,21,88,156
28,21,88,156
28,21,88,156
28,21,88,156
28,21,88,156
28,22,00,809
28,22,00,809
Total Shareholders
3,00,106
2,85,461
2,36,908
2,32,685
2,09,931
1,99,451
1,92,630
1,93,949
1,95,059
1,92,724
1,90,210
1,98,789

Mutual Funds that own Glenmark Pharmaceuticals Ltd Stock

Check out the Mutual Funds with significant holdings in Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Glenmark Pharmaceuticals Ltd.

  • Glenmark Pharmaceuticals Ltd Earnings Results

    Glenmark Pharmaceuticals Ltd’s net profit jumped 72.31% since last year same period to ₹610.35Cr in the Q2 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 1202.22% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Glenmark Pharmaceuticals Ltd Dividends September,2025

    In the quarter ending June 2025, Glenmark Pharmaceuticals Ltd has declared dividend of ₹2.50 per share on 26 Sep 2025 - translating a dividend yield of 0.26%.

    Read More about Dividends

Indices Featuring Glenmark Pharmaceuticals Ltd Stock

Check stock indices that include Glenmark Pharmaceuticals Ltd.

Nifty Healthcare

₹15,031.25

0.55 (▲81.9%)

NIFTY PHARMA

₹22,998.30

0.59 (▲135.3%)

Nifty Midcap 150

₹22,395.40

-0.11 (▲-24.7%)

BSE Healthcare

₹44,883.80

0.36 (▲163.2%)

Nifty Alpha 50

₹52,105.25

0.03 (▲17.1%)

Nifty MidSmallcap 400

₹20,308.20

-0.15 (▲-30.25%)

S&P BSE 150 MidCap

₹16,523.05

-0.07 (▲-11.67%)

S&P BSE Momentum

₹2,290.45

0.04 (▲0.91%)

Nifty LargeMidcap 250

₹16,915.10

-0.07 (▲-11.45%)

S&P BSE 250 LargeMidCap

₹11,216.60

-0.03 (▲-3.55%)

BSE Mid-Cap

₹47,211.40

-0.04 (▲-18.99%)

Nifty 500

₹23,933.20

-0.06 (▲-14.55%)

S&P BSE 400 MidSmallCap

₹12,216.56

-0.11 (▲-14.01%)

BSE 500

₹37,535.84

-0.05 (▲-18.55%)

Nifty Midcap 100

₹61,043.25

-0.11 (▲-69.9%)

Nifty 200

₹14,579.35

-0.04 (▲-6%)

Insights on Glenmark Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 15.55% to 16.31% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GLENMARK has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 20.62% to 20.73% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, GLENMARK has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 3.26K Cr → 6.24K Cr (in ₹), with an average increase of 24.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 4.65 Cr → 610.35 Cr (in ₹), with an average increase of 91.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, GLENMARK stock has moved up by 5.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 46.65% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 15.06% to 13.97% in Sep 2025 quarter

Glenmark Pharmaceuticals Ltd Stock Futures & Options Contracts

View the latest movement in Glenmark Pharmaceuticals Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

Glenmark Pharmaceuticals Ltd Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
GLENMARK 30 Dec ₹1960 Call
December 30, 2025
₹1960
₹56.65
0.4
0.71%
GLENMARK 30 Dec ₹2000 Call
December 30, 2025
₹2000
₹40.75
1.05
2.64%
GLENMARK 30 Dec ₹1940 Call
December 30, 2025
₹1940
₹66.9
1.35
2.06%
GLENMARK 30 Dec ₹1900 Call
December 30, 2025
₹1900
₹89.55
1.15
1.3%

Glenmark Pharmaceuticals Ltd Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
GLENMARK 30 Dec Fut
December 30, 2025
-
₹1957
3.32
0.17%
GLENMARK 27 Jan Fut
January 27, 2026
-
₹1968.1
4.12
0.21%
GLENMARK 24 Feb Fut
February 24, 2026
-
₹1976.4
-2.18
-0.11%

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is an Indian pharmaceuticals company listed on the National Stock Exchange and Bombay Stock Exchange. Established in 1977, the company manufactures and distributes branded and generic formulations, active pharmaceutical ingredients (API’s) and biosimilars. It has 18 manufacturing facilities in India, 7 in the U.S., 1 in Brazil and 1 in Mexico that span across the world catering to global requirements. Glenmark has taken several steps towards achieving a healthy presence in the global markets. In addition to its product portfolio, Glenmark’s aggressive acquisition strategy and product launch activities have helped expand its market reach. The company has been awarded numerous accolades over the years, including consecutive years of being ranked amongst the top 1000 world pharmaceutical companies. It continues to be a frontrunner in providing quality and affordable healthcare solutions in India and abroad.

Revenue: ₹6,003.79Cr as on September 2025 (Q2 FY26)
Net Profit: ₹610.43Cr as on September 2025 (Q2 FY26)
Listing date: 07 Feb, 2000
Chairperson Name: Glenn Saldanha
OrganisationGlenmark Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOGlenn Saldanha
E-voting on sharesClick here to vote

FAQs

What is Glenmark Pharmaceuticals Ltd share price today?

Glenmark Pharmaceuticals Ltd share price today stands at ₹1946.2 as on at the close of the market. Glenmark Pharmaceuticals Ltd share today touched a day high of ₹1958 and a low of ₹1937.8.

What is the 52 week high and 52 week low range for Glenmark Pharmaceuticals Ltd share?

Glenmark Pharmaceuticals Ltd touched a 52 week high of ₹2284.8 and a 52 week low of ₹1275.5. Glenmark Pharmaceuticals Ltd share price today i.e. is closed at ₹1946.2, which is -14.82% down from its 52 week high and 52.58% up from its 52 week low.

What is Glenmark Pharmaceuticals Ltd's market capitalisation today?

Glenmark Pharmaceuticals Ltd market capitalisation is ₹54,859.84 Cr as on .

How to buy Glenmark Pharmaceuticals Ltd shares?

To buy Glenmark Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GLENMARK or Glenmark Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Glenmark Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Glenmark Pharmaceuticals Ltd trading volume today?

Glenmark Pharmaceuticals Ltd trading volume is 6.88L as on . This means that 6.88L shares of Glenmark Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.